KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 92 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $21,920,000 | +397.6% | 292,349 | +399.8% | 0.84% | +641.6% |
| Q2 2015 | $4,405,000 | +485.8% | 58,490 | +289.9% | 0.11% | +438.1% |
| Q1 2015 | $752,000 | -85.4% | 15,000 | -89.9% | 0.02% | -88.6% |
| Q4 2014 | $5,164,000 | +5.9% | 148,900 | 0.0% | 0.18% | +0.5% |
| Q3 2014 | $4,878,000 | -9.2% | 148,900 | +6.4% | 0.18% | -24.9% |
| Q2 2014 | $5,372,000 | +12.6% | 140,000 | +16.7% | 0.24% | -1.2% |
| Q1 2014 | $4,771,000 | +921.6% | 120,000 | +860.0% | 0.25% | +675.0% |
| Q4 2013 | $467,000 | +2.4% | 12,500 | +25.0% | 0.03% | -22.0% |
| Q3 2013 | $456,000 | +68.3% | 10,000 | 0.0% | 0.04% | +46.4% |
| Q2 2013 | $271,000 | – | 10,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 1,810,518 | $71,986,000 | 2.98% |
| Redmile Group, LLC | 443,326 | $17,627,000 | 2.10% |
| AlpInvest Partners B.V. | 22,224 | $884,000 | 2.04% |
| SENZAR ASSET MANAGEMENT, LLC | 89,500 | $3,558,000 | 1.88% |
| Aureus Asset Management, LLC | 136,305 | $5,419,000 | 1.39% |
| PFM Health Sciences, LP | 1,003,492 | $39,899,000 | 0.72% |
| REGENTATLANTIC CAPITAL LLC | 176,454 | $7,016,000 | 0.68% |
| Ghost Tree Capital, LLC | 25,000 | $994,000 | 0.59% |
| HAMILTON LANE ADVISORS LLC | 30,264 | $1,203,000 | 0.48% |
| Pentwater Capital Management LP | 390,000 | $15,506,000 | 0.41% |